The Effect of Augmented Reality Based Telerehabilitation Application on Neuromuscular and Sensorimotor Parameters in Multiple Sclerosis Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed with relapsing remitting MS by a neurologist,
- Having a disability level between 1 and 5 according to the Expanded Disability Status Scale (EDSS),
- Those who get over 24 points in the Standardized Mini Mental State Test (SMMT),
- Those who have not had an MS attack in the last three months,
- Volunteer individuals
Exclusion Criteria:
- Receiving corticosteroid therapy in the last 4 weeks,
- Having additional neurological disease that may cause balance disorder
- Individuals who have had surgery related to the spine, hip, knee or ankle
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Group 1
Patients in this group will receive spinal stabilization training through augmented reality based telerehabilitation application.
|
Spinal stabilization training with augmented reality-based telerehabilitation will be applied twice a week for 8 weeks.
|
|
ACTIVE_COMPARATOR: Group 2
Patients in this group will receive spinal stabilization training face-to-face.
|
Spinal stabilization training will be applied face-to-face twice a week for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Balance
Time Frame: Change from baseline at 8 weeks
|
MiniBESTest will be used to evaluate the static and dynamic balance.It consists of 14 questions including antisipatuar postural reaction, reactive postural control, sensory orientation and dynamic balance.
The test is scored between 0-28 points.
The highest score indicates good balance.
|
Change from baseline at 8 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle Activity
Time Frame: Change from baseline at 8 weeks
|
An 8-channel superficial EMG system will be used to measure signals from the quadriceps and tibialis anterior muscles.Electrodes will be placed according to SENIAM criteria.The signals received from the muscles of the individuals will be recorded during standing up from sitting.
As a result, the average muscle activations of the muscles during the activity will be numerically recorded in %MVIC.
|
Change from baseline at 8 weeks
|
|
Core Muscle Endurance-Trunk Flexor
Time Frame: Change from baseline at 8 weeks
|
The trunk flexor test will be performed with the arms crossed over the thorax, the trunk at 60 degrees of flexion, and the knees and hips flexed to 90 degrees.
The test will be finished when the participant is unable to maintain the position.
The time will be recorded.As the time increases, the endurance decreases.
|
Change from baseline at 8 weeks
|
|
Core Muscle Endurance- Trunk Extansor
Time Frame: Change from baseline at 8 weeks
|
The trunk extensor test will be performed in the prone position, with the pelvis, hips and knees fixed to the bed.
The participant will be asked to cross his arms over his body and position his body horizontally.
The test will be finished when the participant is unable to maintain the horizontal position.
The time will be recorded.
As the time increases, the endurance decreases.
|
Change from baseline at 8 weeks
|
|
Core Muscle Endurance- Side Bridge
Time Frame: Change from baseline at 8 weeks
|
While the participants are in the side-lying position, they will raise their hips and align their bodies in a straight line by getting support from their feet and elbows.
The time will be recorded by asking them to maintain the position as much as possible.As the time increases, the endurance decreases.
|
Change from baseline at 8 weeks
|
|
Trunk Position Sense
Time Frame: Change from baseline at 8 weeks
|
Inclinometer will be positioned at spinous process of 1th thoracic vertebrae and 1 sacral during trunk position sense assessment.
Subject will be retreated to neutral position and asked to come back taught position while eyes closed.
Test will be repeated 3 times and angle of deviation from 30 degree flexion position will be recorded and the average of the results will be taken.As the deflection angle increases, the sense of position deteriorates.
As the deflection angle increases, the sense of position deteriorates.
|
Change from baseline at 8 weeks
|
|
Spinal mobility
Time Frame: Change from baseline at 8 weeks
|
Spinal Mouse device will be used to evaluate spinal mobility.
Measurements will be made between the spinous process of the 7th cervical vertebra and approximately the level of the 3rd sacral vertebra.
Maximum degrees of right-left lateral flexion in the frontal plane and maximum degrees of flexion-extension in the sagittal plane will be measured and recorded.As the degree increases, the deformity also increases.
|
Change from baseline at 8 weeks
|
|
Fatique-Fatigue Severity Scale
Time Frame: Change from baseline at 8 weeks
|
The Fatigue Severity Scale, which rates the severity of fatigue symptoms, consists of questions expressing 9 different conditions.A high score indicates increased fatigue severity.
Patients with a score of <4 will be considered "not tired", and patients with a score of >4 will be considered "tired".
|
Change from baseline at 8 weeks
|
|
Fatigue- Fatigue Impact Scale
Time Frame: Change from baseline at 8 weeks
|
Each question ranges from 0 (no problem) to 4 (maximum problem) in the scale that evaluates cognitive status, physical condition and psychological status.
High scores indicate fatigue.
|
Change from baseline at 8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2022-985
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.